Latest News

Check out our Kolling Institute Year in Review 2022 celebrating our research success. It highlights our world-leading translational research and our impact across our priority research areas. Click on the link here.
Read more

Researchers at the Kolling Institute have made important progress towards the development of new treatments for chronic pain by identifying a small group of cells which can control pain responses. The breakthrough comes as approximately 20 per cent of the world’s population suffers from chronic pain, including around 3.4 million Australians. Dr Neda Assareh, a neuroscientist research fellow from th.....
Read more

Our researchers at the Kolling Institute are encouraging those with osteoarthritis to rely on treatments with a proven track record and avoid quick fixes without the data to show they work. The comments follow a steady rise in osteoarthritis cases nationally, with around three million Australians now living with the condition, and many forced to retire early. The rise in cases has coincided with st.....
Read more

A new study by researchers at the Kolling Institute estimates more than 800 million people will be living with low back pain by 2050, a 36 percent increase from 2020. The prediction follows an analysis of 30 years of global health data from over 200 countries. Modelling shows the number of back pain cases globally will rise to 843 million people by 2050, while in Australia, it’s expected there will.....
Read more

Researchers from the Kolling Institute have led an international study investigating why some people spontaneously recover from whiplash following a motor vehicle collision, while others don’t. Their work has uncovered new evidence indicating it may relate to the health of muscles and stress. More than 140 people were recruited to the longitudinal study, which involved research teams from the Unite.....
Read more

Researchers based at Royal North Shore Hospital have launched the first study of its kind in the world to support those with a spinal cord injury. The team from the Kolling Institute’s John Walsh Centre for Rehabilitation Research is now seeking recruits for the clinical trial which is investigating the benefits of an approach combining breathing techniques with heart rate feedback. Study lead Prof.....
Read more

In a sign of the growing neuroscience expertise at the Kolling Institute, internationally recognised Meniere’s disease expert Professor Jose Antonio Lopez Escamez has relocated from Spain to the institute. Professor Lopez Escamez has launched an exciting new international research program into the disease, extending his body of work in Europe. Meniere’s disease is a rare disease of the inner ear th.....
Read more

In an exciting announcement, three clinical research fellows have been appointed within the Northern Sydney Local Health District (NSLHD). The positions are part of an initiative developed by the University of Sydney’s Faculty of Medicine and Health Northern Sydney (Arabanoo) Precinct and the NSLHD. The new roles will drive interdisciplinary research activity, develop research capabilities and incr.....
Read more

In a sign of the international impact of our research at the Kolling Institute, a prestigious award has been presented to Professor Chris Little during the World Congress on Osteoarthritis in Denver, Colorado. More than 700 researchers and clinicians attended the event where Professor Little was presented with the 2023 Basic Science Research Award by the Osteoarthritis Research Society Internationa.....
Read more

With ovarian cancer continuing to have a devastating outcome for many women, new research at the Kolling Institute is offering hope. The disease has the lowest survival rate of any women’s cancer, with only 48 per cent of women living beyond five years after diagnosis. Ovarian cancer is often diagnosed late because the symptoms are vague, like bloating, nausea, indigestion, excessive tiredness, and.....
Read more